These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 343907)

  • 41. Bis chloroethyl nitrosourea, vincristine, dimethyl triazeno imidazole carboxamide and chlorpromazine combination chemotherapy in disseminated malignant melanoma.
    McKelvey EM; Luce JK; Vaitkevicius VK; Talley RW; Bodey GP; Lane M; Moon TE
    Cancer; 1977 Jan; 39(1):5-10. PubMed ID: 832251
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Ineffectiveness of adjuvant chemotherapy using DTIC and cyclophosphamide in patients with resectable metastatic melanoma.
    Balch CM; Murray D; Presant C; Bartolucci AA
    Surgery; 1984 Apr; 95(4):454-9. PubMed ID: 6369594
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Cyclophosphamide plus 5-(3,3-dimethyl-1-triazeno)-imidazole-4-carboxamide (DTIC) with or without Corynebacterium parvum in metastatic malignant melanoma.
    Presant CA; Bartolucci AA; Smalley RV; Vogler WR
    Cancer; 1979 Sep; 44(3):899-905. PubMed ID: 383276
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Influence of therapy on the antioxidant status in patients with melanoma.
    Gadjeva V; Dimov A; Georgieva N
    J Clin Pharm Ther; 2008 Apr; 33(2):179-85. PubMed ID: 18315784
    [TBL] [Abstract][Full Text] [Related]  

  • 45. A randomized comparison of cyclophosphamide, DTIC with or without piperazinedione in metastatic malignant melanoma.
    Presant CA; Bartolucci AA; Balch C; Troner M
    Cancer; 1982 Apr; 49(7):1355-7. PubMed ID: 7037162
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Combination chemotherapy of MOPP-resistant Hodgkin's disease with adriamycin, bleomycin, dacarbazine and vinblastine (ABDV).
    Case DC; Young CW; Lee BJ
    Cancer; 1977 Apr; 39(4):1382-6. PubMed ID: 66972
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Chemotherapy of disseminated malignant melanoma with imidazol carboxamide (DTIC) and cyclophosphamide. Preliminary results.
    Rudolf Z; Plesnicar S
    Anticancer Res; 1982; 2(1-2):37-9. PubMed ID: 7051959
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Randomized phase III study of temozolomide versus dacarbazine in the treatment of patients with advanced metastatic malignant melanoma.
    Middleton MR; Grob JJ; Aaronson N; Fierlbeck G; Tilgen W; Seiter S; Gore M; Aamdal S; Cebon J; Coates A; Dreno B; Henz M; Schadendorf D; Kapp A; Weiss J; Fraass U; Statkevich P; Muller M; Thatcher N
    J Clin Oncol; 2000 Jan; 18(1):158-66. PubMed ID: 10623706
    [TBL] [Abstract][Full Text] [Related]  

  • 49. [Chemotherapy of malignant melanoma. Results of a controlled clinical trial comparing vincristine + dacarbazin (DTIC) with and without duborimycin (author's transl)].
    Chauvergne J; Clavel B; Klein T; Pommatau E
    Bull Cancer; 1978; 65(2):107-9. PubMed ID: 359067
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Combination chemotherapy with adramycin (NSC-123127) and dimethyl triazeno imidazole carboxamide (DTIC) (NSC-45388) in children with metastatic solid tumors.
    Cangir A; Morgan SK; Land VJ; Pullen J; Starling SA; Nitschke R
    Med Pediatr Oncol; 1976; 2(2):183-90. PubMed ID: 958160
    [TBL] [Abstract][Full Text] [Related]  

  • 51. [Chemotherapy of malignant melanoma using DTIC].
    Zaumseil RP; Fiedler H; Lübbe D
    Dermatol Monatsschr; 1977 Nov; 163(11):905-14. PubMed ID: 590586
    [No Abstract]   [Full Text] [Related]  

  • 52. Letter: Disseminated intravascular coagulation syndrome with metastatic melanoma: Remission after treatment with 5-(3,3-dimethyl-1-triazeno) imidazole-4-carboxamide (DTIC).
    Susens GP; Hendrickson C; Barto DA; Sams BJ
    Ann Intern Med; 1976 Feb; 84(2):175-6. PubMed ID: 1252046
    [No Abstract]   [Full Text] [Related]  

  • 53. Controlled study of DTIC versus DTIC plus epirubicin in metastatic malignant melanoma.
    Lopez M; Perno CF; Di Lauro L; Papaldo P; Ganzina F; Barduagni A
    Invest New Drugs; 1984; 2(3):319-22. PubMed ID: 6392148
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Treatment of advanced Hodgkin's disease with adriamycin, bleomycin, vinblastine, and imidazole carboxamide (ABVD) after failure of MOPP therapy.
    Krikorian JG; Portlock CS; Rosenberg SA
    Cancer; 1978 Jun; 41(6):2107-11. PubMed ID: 77716
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Chemoimmunotherapy of disseminated malignant melanoma with dimethyl triazeno imidazole carboxamide and bacillus calmette--guérin.
    Gutterman JU; Mavligit G; Gottlieb JA; Burgess MA; McBride CE; Einhorn L; Freireich EJ; Hersh EM
    N Engl J Med; 1974 Sep; 291(12):592-7. PubMed ID: 4851001
    [No Abstract]   [Full Text] [Related]  

  • 56. Combination chemotherapy of metastatic malignant schwannoma with vincristine, adriamycin, cyclophosphamide, and imidazole carboxamide: a case report.
    Goldman RL; Jones SE; Heusinkveld RS
    Cancer; 1977 May; 39(5):1955-8. PubMed ID: 858125
    [TBL] [Abstract][Full Text] [Related]  

  • 57. [Polychemotherapy with 5-(3,3 dimethyl-1-triazeno)imidazole-4-carboxamide (DTIC; NSC-45388), 1,3-bis (2-chloroethyl)-1-nitrosourea (BCNU, NSC-409962) and vincristine (NSC-67574) in the metastatic phase of melanoma].
    Beretta G; Bajetta E; Bonadonna G; Tancini G; Orefice S; Veronesi U
    Tumori; 1973; 59(3):239-48. PubMed ID: 4729646
    [No Abstract]   [Full Text] [Related]  

  • 58. Comparative evaluation of three combination regimens for advanced malignant melanoma: results of an international cooperative study.
    Beretta G; Bonadonna G; Cascinelli N; Morabito A; Veronesi U
    Cancer Treat Rep; 1976 Jan; 60(1):33-40. PubMed ID: 1000518
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Fotemustine compared with dacarbazine in patients with disseminated malignant melanoma: a phase III study.
    Avril MF; Aamdal S; Grob JJ; Hauschild A; Mohr P; Bonerandi JJ; Weichenthal M; Neuber K; Bieber T; Gilde K; Guillem Porta V; Fra J; Bonneterre J; Saïag P; Kamanabrou D; Pehamberger H; Sufliarsky J; Gonzalez Larriba JL; Scherrer A; Menu Y
    J Clin Oncol; 2004 Mar; 22(6):1118-25. PubMed ID: 15020614
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Cisplatin and carboplatin combination as second-line chemotherapy in dacarbazine-resistant melanoma patients.
    Güven K; Kittler H; Wolff K; Pehamberger H
    Melanoma Res; 2001 Aug; 11(4):411-5. PubMed ID: 11479430
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.